Inspiratory muscle load and capacity in chronic heart failure.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 1747026)

Published in Thorax on June 01, 2004

Authors

N Hart1, M T Kearney, N B Pride, M Green, F Lofaso, A M Shah, J Moxham, M I Polkey

Author Affiliations

1: Respiratory Muscle Laboratory, Royal Brompton Hospital, London, UK. dmhart@aol.com

Articles cited by this

THE INTRAPLEURAL PRESSURE IN CONGESTIVE HEART FAILURE AND ITS CLINICAL SIGNIFICANCE. J Clin Invest (1934) 6.96

A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis (1982) 3.10

Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure. Lancet (1998) 2.05

Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01

Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J (1990) 2.00

Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation (1988) 1.93

Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest (2001) 1.82

Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.76

Is nedocromil sodium effective treatment for asthma? Eur Respir J (1993) 1.67

Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation (1995) 1.49

A novel clinical test of respiratory muscle endurance. Eur Respir J (2002) 1.40

Measurement of inspiratory muscle performance with incremental threshold loading. Am Rev Respir Dis (1987) 1.29

Mechanism of decreased left ventricular stroke volume during inspiration in man. Circulation (1984) 1.25

Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation (1992) 1.23

Measuring ventilatory muscle endurance in humans as sustainable inspiratory pressure. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.22

Respiratory muscle strength in congestive heart failure. Chest (1990) 1.20

Ventilation and gas exchange during exercise in severe chronic heart failure. Am Rev Respir Dis (1984) 1.20

Symptoms limiting exercise in chronic heart failure. Br Med J (Clin Res Ed) (1986) 1.14

Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med (2002) 1.08

Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis (1992) 1.03

Effect of severe isolated unilateral and bilateral diaphragm weakness on exercise performance. Am J Respir Crit Care Med (2002) 1.01

Respiratory muscle fatigue during cardiogenic shock. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.00

Respiratory muscles and dyspnea. Clin Chest Med (1988) 1.00

Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur Respir J (1994) 0.96

Exercise hyperpnea in chronic heart failure: relationships to lung stiffness and expiratory flow limitation. J Appl Physiol (1985) (2002) 0.95

Diaphragm strength in chronic heart failure. Am J Respir Crit Care Med (1999) 0.92

Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation (1997) 0.92

Ventilatory responses to inspiratory threshold loading and role of muscle fatigue in task failure. J Appl Physiol (1985) (1994) 0.91

Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J Am Coll Cardiol (1991) 0.90

Evidence of reduced respiratory muscle endurance in patients with heart failure. J Am Coll Cardiol (1994) 0.90

Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol (1985) (1998) 0.89

Respiratory muscle strength in chronic heart failure. Thorax (1995) 0.88

Introduction to a new inspiratory threshold loading device. Eur Respir J (1998) 0.85

The use of exercise testing and other methods in the investigation of dyspnea. Clin Chest Med (1984) 0.81

The effects of learning on the ventilatory responses to inspiratory threshold loading. Am J Respir Crit Care Med (1998) 0.81

The sensation of dyspnea during exercise is not determined by the work of breathing in patients with heart failure. J Am Coll Cardiol (1996) 0.80

Inspiratory muscle endurance in patients with chronic heart failure. Heart (1996) 0.80

Inspiratory muscle relaxation rate slows during exhaustive treadmill walking in patients with chronic heart failure. Am J Respir Crit Care Med (2001) 0.80

Static lung compliance in chronic heart failure: relation with dyspnoea and exercise capacity. Thorax (1995) 0.78

Diaphragmatic function after intense exercise in congestive heart failure patients. Eur Respir J (2002) 0.78

A breakthrough in the functional evaluation of the inspiratory muscle pump. Eur Respir J (2002) 0.77

Future perspectives in the management of congestive heart failure. Am J Cardiol (1990) 0.76

The presence of emphysema does not affect the systemic bioactivity of inhaled fluticasone in severe chronic obstructive pulmonary disease. Br J Clin Pharmacol (2004) 0.76

Articles by these authors

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med (1995) 6.97

Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A (1967) 5.55

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet (1993) 5.43

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65

An adenovirus E1a protein region required for transformation and transcriptional repression. Cell (1986) 4.56

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27

Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24

Hyponatraemia and catatonic stupor after taking "ecstasy". BMJ (1993) 4.02

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01

Fake artesunate in southeast Asia. Lancet (2001) 3.84

Functional domains of adenovirus type 5 E1a proteins. Cell (1987) 3.79

A single subunit from avian myeloblastosis virus with both RNA-directed DNA polymerase and ribonuclease H activity. Proc Natl Acad Sci U S A (1973) 3.71

Oncogenic viruses. Annu Rev Biochem (1970) 3.65

Persistence of avian influenza viruses in water. Avian Dis (1990) 3.63

Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol (1991) 3.61

Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells. Virology (1971) 3.54

Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses. Proc Natl Acad Sci U S A (1970) 3.47

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J (2002) 3.22

An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax (1975) 3.13

Occupational asthma in an electronics factory. Thorax (1979) 3.03

Recent trends in physician diagnosed COPD in women and men in the UK. Thorax (2000) 3.02

Biochemical studies on adenovirus multiplication, XIX. Resolution of late viral RNA species in the nucleus and cytoplasm. Proc Natl Acad Sci U S A (1971) 3.02

Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation. Nature (1976) 3.01

Isolation of a human papillomavirus from a patient with epidermodysplasia verruciformis: presence of related viral DNA genomes in human urogenital tumors. Proc Natl Acad Sci U S A (1982) 2.90

Immunoautoradiographic detection of proteins after electrophoretic transfer from gels to diazo-paper: analysis of adenovirus encoded proteins. Proc Natl Acad Sci U S A (1981) 2.88

Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II. Genes Dev (1993) 2.87

The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond) (1985) 2.83

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA (1990) 2.82

Biochemical studies on adenovirus multiplication. IX. Chemical and base composition analysis of 28 human adenoviruses. Proc Natl Acad Sci U S A (1965) 2.79

DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J Clin Microbiol (1995) 2.69

Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol (1993) 2.59

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55

Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum (1998) 2.51

Measurement of twitch transdiaphragmatic, esophageal, and endotracheal tube pressure with bilateral anterolateral magnetic phrenic nerve stimulation in patients in the intensive care unit. Crit Care Med (2001) 2.47

Viral RNA subunits in cells transformed by RNA tumor viruses. Science (1972) 2.44

The effects of ventilation of dogs with different gas mixtures on airway calibre and lung mechanics. J Physiol (1966) 2.42

Carrying large fuel loads during sustained bird flight is cheaper than expected. Nature (2001) 2.41

Mechanism of carcinogenesis by RNA tumor viruses. 3. Formation of RNA, DNA complex and duplex DNA molecules by the DNA polymerase (s) of avian myeloblastosis virus. Proc Natl Acad Sci U S A (1970) 2.37

Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Proc Natl Acad Sci U S A (1975) 2.37

Determinants of maximal expiratory flow from the lungs. J Appl Physiol (1967) 2.36

Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation (2005) 2.30

Reduction of transmission of shigellosis by control of houseflies (Musca domestica) Lancet (1991) 2.30

Work-related respiratory disease in employees leaving an electronics factory. Thorax (1979) 2.29

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28

Formation of viral RNA-DNA hybrid molecules by the DNA polymerase of sarcoma-leukaemia viruses. Nature (1970) 2.27

Effects of pH, temperature, and salinity on persistence of avian influenza viruses in water. Avian Dis (1990) 2.24

The genome of RNA tumor viruses contains polyadenylic acid sequences. Proc Natl Acad Sci U S A (1972) 2.23

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol (2005) 2.23

The assessment of airflow obstruction. Role of measurements of airways resistance and of tests of forced expiration. Br J Dis Chest (1971) 2.22

Virus specific RNA in cells transformed by RNA tumour viruses. Nat New Biol (1971) 2.22

Survival among women with triple receptor-negative breast cancer and brain metastases. Ann Oncol (2009) 2.21

The mechanism of viral carcinogenesis by DNA mammalian viruses: viral-specific RNA in polyribosomes of adenovirus tumor and transformed cells. Proc Natl Acad Sci U S A (1966) 2.19

Mechanism of viral carcinogenesis by DNA mammalian viruses. VII. Viral genes transcribed in adenovirus type 2 infected and transformed cells. Proc Natl Acad Sci U S A (1970) 2.17

A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol (1995) 2.16

Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology (1967) 2.16

Evaluation of an inspiratory muscle trainer in healthy humans. Respir Med (2001) 2.16

Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax (2003) 2.15

Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies. Virology (1979) 2.14

Effects of temperature on Vitalograph spirometer readings. Thorax (1983) 2.13

Avian influenza viruses from migratory and resident ducks of coastal Louisiana. Avian Dis (1990) 2.12

Quadriceps muscle strength in scoliosis. Eur Respir J (2009) 2.11

Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol (1967) 2.10

Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J (1997) 2.10

The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun (2000) 2.10

RNA-directed DNA polymerase--properties and functions in oncogenic RNA viruses and cells. Prog Nucleic Acid Res Mol Biol (1974) 2.10

Molecular interactions of ribosomal components. I. Identification of RNA binding sites for individual 30S ribosomal proteins. Mol Gen Genet (1970) 2.09

ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to the 90-kDa heat shock protein (hsp90) and the 94-kDa glucose regulated protein (GRP94). J Biol Chem (1987) 2.09

Human adenoviruses: growth, purification, and transfection assay. Methods Enzymol (1979) 2.06

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05

Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J (2005) 2.04

Preparation and characterization of highly radioactive in vitro labeled adenovirus DNA and DNA restriction fragments. Biochemistry (1977) 2.04

Variability of maximum expiratory flow-volume curves. J Appl Physiol (1974) 2.03

Sequence relatedness between the subunits of avian myeloblastosis virus reverse transcriptase. J Biol Chem (1975) 2.01

Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med (1994) 1.99

Pulmonary mechanics in patients with respiratory muscle weakness. Am Rev Respir Dis (1977) 1.98

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol (2005) 1.96

Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation (1999) 1.96

Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax (2007) 1.94

Biochemical studies on adenovirus multiplication. XV. Transcription of the adenovirus type II genome during productive infection. Virology (1969) 1.94

Migration along orthodromic sun compass routes by arctic birds. Science (2001) 1.92

Molecular interactions of ribosomal components. II. Site-specific complex formation between 30S proteins and ribosomal RNA. Mol Gen Genet (1971) 1.91

Assessment of diaphragm weakness. Am Rev Respir Dis (1988) 1.90

The stress response in Chinese hamster ovary cells. Regulation of ERp72 and protein disulfide isomerase expression and secretion. J Biol Chem (1990) 1.89

Fall in vital capacity with posture. Br J Dis Chest (1985) 1.89

Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine (2001) 1.86

An anatomical explanation for good-prognosis rheumatoid arthritis. Lancet (1999) 1.84

Indole-3-Acetic Acid and Flowering. Science (1948) 1.84

Ribonuclease H: a ubiquitous activity in virions of ribonucleic acid tumor viruses. J Virol (1972) 1.84

Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J (2003) 1.84

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83

Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2. Virology (1979) 1.83

ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J Biol Chem (1990) 1.83

Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses. Nat New Biol (1971) 1.80

A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol (1985) (2007) 1.80